What Are Wall Street Analysts’ Target Price for Regeneron Pharmaceuticals Stock?
Regeneron Pharmaceuticals, Inc. (REGN) is a biotechnology company headquartered in Tarrytown, New York, with a market capitalization of around $62.3 billion. The company specializes in discovering, developing, manufacturing, and commercializing …